Virtici, LLC

Publicly observed

Seattle, United States

Seen in a public record (e.g. a government grant database); not otherwise verified.

Details and provenance

Item	Value	Source	Status
Country	US	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
City / locality	Seattle	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
Name	Virtici, LLC	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed
UEI (U.S. federal entity ID)	V29SWGG4MQ64	NIH RePORTER (opens in a new tab) 28 Sept 2026	Publicly observed

Recorded events

Grant10 Sept 2026Publicly observed
NIH SBIR/STTR award: A Novel Sublingual Vaccine for Preventing andTreating Periodontitis
USD 306,464.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Grant2 Sept 2026Publicly observed
NIH SBIR/STTR award: A Novel Preventative and Treatment for Klebsiella Pneumoniae Infection
USD 306,500.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant26 Aug 2026Publicly observed
NIH SBIR/STTR award: A Bioengineered Probiotic for Resetting Immune Function in Rheumatoid Arthritis
USD 306,341.00 · National Institute of Arthritis and Musculoskeletal and Skin Diseases · Source: NIH RePORTER (opens in a new tab)
Grant13 Aug 2026Publicly observed
NIH SBIR/STTR award: A Novel Immune-modulating Probiotic for Treating Rheumatoid Arthritis
USD 300,222.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Grant8 Aug 2025Publicly observed
NIH SBIR/STTR award: A Novel Anti-infective Therapy for Treating Periodontitis
USD 308,096.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Grant8 Aug 2025Publicly observed
NIH SBIR/STTR award: A Novel Anti-infective Therapy for Treating Periodontitis
USD 309,038.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Grant19 Sept 2024Publicly observed
NIH SBIR/STTR award: A Novel Peptide for the Oral Treatment and Prevention of P. Gingivalis Infection
USD 698,684.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Grant1 Apr 2022Publicly observed
NIH SBIR/STTR award: A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
USD 903,600.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Grant1 Apr 2022Publicly observed
NIH SBIR/STTR award: A Novel Bispecific Antibody for the Treatment of Idiopathic Pulmonary Fibrosis
USD 999,989.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)

Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.